Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash from Financing Activities (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Cash from Financing Activities data on record, last reported at -$19.0 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 106.87% year-over-year to -$19.0 million; the TTM value through Dec 2025 reached -$42.6 million, down 116.8%, while the annual FY2025 figure was $207.1 million, 3160.49% up from the prior year.
  • Cash from Financing Activities reached -$19.0 million in Q4 2025 per PAHC's latest filing, down from $16.3 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $276.3 million in Q4 2024 and bottomed at -$32.2 million in Q1 2025.
  • Average Cash from Financing Activities over 5 years is $11.7 million, with a median of $1.5 million recorded in 2023.
  • The widest YoY moves for Cash from Financing Activities: up 1979.09% in 2024, down 2352.85% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$14.6 million in 2021, then soared by 125.49% to $3.7 million in 2022, then crashed by 495.72% to -$14.7 million in 2023, then surged by 1979.09% to $276.3 million in 2024, then tumbled by 106.87% to -$19.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$19.0 million in Q4 2025, $16.3 million in Q3 2025, and -$7.8 million in Q2 2025.